Anlon Healthcare Secures In-Principle Approval for Share Swap Preferential Issue
Anlon Healthcare Ltd 路 Others (Uncategorized) 路 29 Oct 2026, 10:43 pm
Anlon Healthcare Secures In-Principle Approval for Share Swap Preferential Issue Anlon Healthcare Limited received 'In-Principle' approval from both the NSE and BSE on 28th Oct'26 for the proposed issuance of 8,05,35,651 equity shares with a face value of Rs. 2 each. The allotment will be executed on a preferential basis pursuant to a proposed share swap under Chapter V of SEBI (ICDR) Regulations, 2018. The approvals were communicated via NSE letter no. NSE/LIST/56913 and BSE letter no. LOD/PREF/DA/FIP/1029/2026-27.
Original exchange filing (PDF)
More announcements from Anlon Healthcare Ltd
- We have attached herewith earning call transcript for the H1/Q2 FY-27. Kindly take the same on your record. Thank you. 路 06 Nov 2026
- We have attached herewith link of Investor Call recording held on Tuesday, November 03, 2026. Kindly take the same on your record. Thank you. 路 04 Nov 2026
- We have attached herewith Investor Presentation as per Regulation 30 of SEBI (LODR) Regulation, 2015. Kindly take the same on your record. Thank you. 路 31 Oct 2026
- We have attached herewith Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2026. Kindly take the same on your record. Thank you. 路 29 Oct 2026
- We have attached herewith outcome of Board Meeting held on Thursday, October 29, 2026. Kindly take the same on your record. Thank you. 路 29 Oct 2026
- Anlon Healthcare Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 29 Oct 2026
- We have attached herewith invitation for investor earning call. Kindly take the same on your record. Thank you. 路 03 Nov 2026
- Anlon Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/10/2026 ,inter alia, to consider and approve the Unaudited Standalone and .... 路 29 Oct 2026
